The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.

Показать другие версии (1)

INTRODUCTION: The purpose of the present study was to investigate the relationship of expression of hypoxia inducible factor (HIF)-1α-modifying enzymes prolyl hydroxylase (PHD)1, PHD2 and PHD3 to response of tumours and survival in breast cancer patients enrolled in a phase II trial of neoadjuvant a...

Полное описание

Библиографические подробности
Главные авторы:	Fox, S, Generali, D, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Mele, T, Dogliotti, L, Bottini, A, Harris, A
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Схожие документы

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
по: Fox, S, и др.
Опубликовано: (2011)

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
по: Mele, T, и др.
Опубликовано: (2010)

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
по: Mele, T, и др.
Опубликовано: (2010)

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer
по: Generali, D, и др.
Опубликовано: (2007)

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
по: Generali, D, и др.
Опубликовано: (2007)

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
по: Generali, D, и др.
Опубликовано: (2009)

Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
по: Generali, D, и др.
Опубликовано: (2009)

Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
по: Generali, D, и др.
Опубликовано: (2008)

Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
по: Generali, D, и др.
Опубликовано: (2006)

Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.
по: Generali, D, и др.
Опубликовано: (2006)

Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
по: Generali, D, и др.
Опубликовано: (2006)

Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial design.
по: Generali, D, и др.
Опубликовано: (2011)

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.
по: Generali, D, и др.
Опубликовано: (2008)

Effect of primary letrozole (LET) vs letrozole plus metronomic cyclophosphamide (LET-CYC) on Treg infiltration in ER plus ve breast cancer.
по: Fox, S, и др.
Опубликовано: (2006)

DOWN-REGULATION OF HYPOXIA INDUCIBILE FACTOR-1 alpha (HIF-1 alpha) EXPRESSION, THROUGH mTOR PATHWAY, BY LETROZOLE (FEMARA (R)) IN ER plus ve BREAST CANCER PATIENTS: CLINICAL IMPLICATIONS
по: Foroni, C, и др.
Опубликовано: (2009)

Prolyl hydroxylases and therapeutics.
по: Smith, T, и др.
Опубликовано: (2010)

Differential prolyl hydroxylation by six Physcomitrella prolyl-4 hydroxylases
по: Christine Rempfer, и др.
Опубликовано: (2024-12-01)

Regulation of HIF: prolyl hydroxylases.
по: Stolze, I, и др.
Опубликовано: (2006)

Substrate selectivity of prolyl hydroxylases
по: McDonough, M
Опубликовано: (2018)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
по: Jie Lun, и др.
Опубликовано: (2023-05-01)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
по: Chowdhury, R, и др.
Опубликовано: (2013)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
по: Flashman, E, и др.
Опубликовано: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
по: Flashman, E, и др.
Опубликовано: (2010)

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
по: Allevi, G, и др.
Опубликовано: (2013)

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
по: Allevi, G, и др.
Опубликовано: (2013)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
по: Hewitson, K, и др.
Опубликовано: (2007)

Bibliometric analysis of hypoxia inducible factor prolyl hydroxylase inhibitor in anemia
по: Li Zheng, и др.
Опубликовано: (2022-09-01)

Structural and mechanistic studies on prolyl hydroxylases
по: Chowdhury, R
Опубликовано: (2008)

Inhibition of a viral prolyl hydroxylase
по: Langley, G, и др.
Опубликовано: (2019)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
по: Schlemminger, I, и др.
Опубликовано: (2003)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
по: Chowdhury, R, и др.
Опубликовано: (2009)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
по: Lippl, K
Опубликовано: (2018)

Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia
по: Jing Li, и др.
Опубликовано: (2022-10-01)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
по: Kiriakidis, S, и др.
Опубликовано: (2017)

Kinetic investigations of the oxygen entry pathway of the hypoxia-inducible factor (HIF) prolyl hydroxylase 2
по: Kearney, L
Опубликовано: (2015)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
по: McNeill, L, и др.
Опубликовано: (2002)

Structural, functional and evolutionary studies on prolyl-hydroxylases
по: Scotti, J
Опубликовано: (2014)

Iron homeostasis and its interaction with prolyl hydroxylases.
по: Mole, D
Опубликовано: (2010)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
по: Figg, WD, и др.
Опубликовано: (2021)

Structure–Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
по: Andrey A. Poloznikov, и др.
Опубликовано: (2022-01-01)